Maged Shenouda, CFO at Relmada Therapeutics, holds 88.33K shares in Relmada Therapeutics (Ticker: RLMD), holds 62.50K shares in Entero Therapeutics (Ticker: ENTO). Most recently, Maged Shenouda Bought ― shares of Relmada Therapeutics on Sep 11, 2024 for an estimated value of 149.70K.
What is the percentage of profitable transactions made by Maged Shenouda?
The percentage of profitable transactions made by Maged Shenouda is 25%.
What is the average return per transaction made by Maged Shenouda?
The average return per transaction made by Maged Shenouda is -11.50%.
What stocks does Maged Shenouda hold?
Maged Shenouda holds: RLMD, ENTO stocks.
What was Maged Shenouda’s latest transaction?
Maged Shenouda latest transaction was an Informative Buy of $149.70K.
What was Maged Shenouda's most profitable transaction?
Maged Shenouda’s most profitable transaction was an Informative Buy of RLMD stock on October 21, 2019. The return on the trade was 10.50%.
What is Maged Shenouda's role in Relmada Therapeutics?
Maged Shenouda's role in Relmada Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.